These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38757872)

  • 21. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
    Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
    Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents.
    Samanta S; Ghosh AK; Ghosh S; Ilina AA; Volkova YA; Zavarzin IV; Scherbakov AM; Salnikova DI; Dzichenka YU; Sachenko AB; Shirinian VZ; Hajra A
    Org Biomol Chem; 2020 Aug; 18(29):5571-5576. PubMed ID: 32662797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety.
    Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W
    Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antitumor activity of 2-aryl-1, 2, 4-triazolo[1, 5-a] pyridine derivatives.
    Tao X; Hu Y
    Med Chem; 2010 Mar; 6(2):65-9. PubMed ID: 20412047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors.
    Zhao T; Yang Y; Yang J; Cui Y; Cao Z; Zuo D; Zhai X
    Bioorg Med Chem; 2021 Sep; 46():116367. PubMed ID: 34425477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives.
    Hung JM; Arabshahi HJ; Leung E; Reynisson J; Barker D
    Eur J Med Chem; 2014 Oct; 86():420-37. PubMed ID: 25194934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights.
    Sheta YS; Sarg MT; Abdulrahman FG; Nossier ES; Husseiny EM
    Bioorg Chem; 2024 Aug; 149():107471. PubMed ID: 38823311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors.
    Matsumoto S; Miyamoto N; Hirayama T; Oki H; Okada K; Tawada M; Iwata H; Nakamura K; Yamasaki S; Miki H; Hori A; Imamura S
    Bioorg Med Chem; 2013 Dec; 21(24):7686-98. PubMed ID: 24216091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Synthesis of New Substituted Pyrazolopyridines with Potent Antiproliferative Activity.
    Giannouli V; Lougiakis N; Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Horne DA; Nam S; Gioti K; Tenta R
    Med Chem; 2020; 16(2):176-191. PubMed ID: 30799794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Antiproliferative Activity of 2,6-Disubstituted Imidazo[4,5-
    Boček Pavlinac I; Dragić M; Persoons L; Daelemans D; Hranjec M
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
    Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
    Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
    Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
    Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Flourophenyl-substituted 5H-indeno[1,2-b]pyridinols with enhanced topoisomerase IIα inhibitory activity: Synthesis, biological evaluation, and structure-activity relationships.
    Kunwar S; Hwang SY; Katila P; Seo M; Man Kadayat T; Kwon Y; Lee ES
    Bioorg Chem; 2021 Nov; 116():105349. PubMed ID: 34536927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.
    Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC
    Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
    Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
    Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
    Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Hashizume H; Nozu K; Yoshida H; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Baba Y; Nakamura Y
    J Med Chem; 2015 Feb; 58(4):1760-75. PubMed ID: 25625617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents.
    Wang R; Chen Y; Yang B; Yu S; Zhao X; Zhang C; Hao C; Zhao D; Cheng M
    Bioorg Chem; 2020 Jan; 94():103474. PubMed ID: 31859010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines.
    Youssef MM; Arafa RK; Ismail MA
    Drug Des Devel Ther; 2016; 10():1133-46. PubMed ID: 27042005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
    Meenakshisundaram S; Manickam M; Pillaiyar T
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900011. PubMed ID: 31596021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.